p53mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p53mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivation
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 1, Pages 84
Publisher
Baishideng Publishing Group Inc.
Online
2015-01-08
DOI
10.3748/wjg.v21.i1.84
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma
- (2014) Domenico Di Marzo et al. CELL CYCLE
- Cellular senescence and its effector programs
- (2014) R. Salama et al. GENES & DEVELOPMENT
- The Activating Transcription Factor 3 Protein Suppresses the Oncogenic Function of Mutant p53 Proteins
- (2014) Saisai Wei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNAs in colorectal cancer as markers and targets: Recent advances
- (2014) Jing-Jia Ye WORLD JOURNAL OF GASTROENTEROLOGY
- α-Lipoic acid prevents p53 degradation in colon cancer cells by blocking NF-κB induction of RPS6KA4
- (2013) Tae-Hyoung Yoo et al. ANTI-CANCER DRUGS
- Antitumour activity on extrinsic apoptotic targets of the triterpenoid maslinic acid in p53-deficient Caco-2 adenocarcinoma cells
- (2013) Fernando J. Reyes-Zurita et al. BIOCHIMIE
- Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
- (2013) A Meijer et al. BRITISH JOURNAL OF CANCER
- Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells
- (2013) Hana Janouskova et al. CANCER LETTERS
- Prodigiosin Rescues Deficient p53 Signaling and Antitumor Effects via Upregulating p73 and Disrupting Its Interaction with Mutant p53
- (2013) B. Hong et al. CANCER RESEARCH
- Over-Expression of Small Ubiquitin-Related Modifier-1 and Sumoylated p53 in Colon Cancer
- (2013) Hongjie Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells
- (2013) Nam Hee Kim et al. CELL CYCLE
- Epicatechin Gallate Impairs Colon Cancer Cell Metabolic Productivity
- (2013) Susana Sánchez-Tena et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Role of Ubiquitin Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies
- (2013) Lindsey N. Micel et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting p53 by small molecules in hematological malignancies
- (2013) Manujendra N Saha et al. Journal of Hematology & Oncology
- Maslinic acid, a triterpenic anti-tumoural agent, interferes with cytoskeleton protein expression in HT29 human colon-cancer cells
- (2013) Eva E. Rufino-Palomares et al. Journal of Proteomics
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Epicatechin Gallate Induces Cell Death via p53 Activation and Stimulation of p38 and JNK in Human Colon Cancer SW480 Cells
- (2013) Isabel Cordero-Herrera et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Hypoxia, Mn-SOD and H2O2 regulate p53 reactivation and PRIMA-1 toxicity irrespective of p53 status in human breast cancer cells
- (2012) Manuel Rieber et al. BIOCHEMICAL PHARMACOLOGY
- Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth
- (2012) YiWei Zhang et al. CANCER BIOLOGY & THERAPY
- miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
- (2012) Helge Siemens et al. CELL CYCLE
- MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling
- (2012) Yong Hoon Cha et al. CELL CYCLE
- Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy
- (2012) Q. Li et al. CLINICAL CANCER RESEARCH
- Different mutation profiles associated to P53 accumulation in colorectal cancer
- (2012) Ignacio López et al. GENE
- SUMOylation of ATF3 alters its transcriptional activity on regulation ofTP53gene
- (2012) Chiung-Min Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- An overview of colorectal cancer survival rates and prognosis in Asia
- (2012) Bijan Moghimi-Dehkordi World Journal of Gastrointestinal Oncology
- A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation
- (2011) Jane M Valentine et al. BMC CANCER
- The natural triterpene maslinic acid induces apoptosis in HT29 colon cancer cells by a JNK-p53-dependent mechanism
- (2011) Fernando J Reyes-Zurita et al. BMC CANCER
- Translational approaches targeting the p53 pathway for anti-cancer therapy
- (2011) Frank Essmann et al. BRITISH JOURNAL OF PHARMACOLOGY
- PRIMA-1Met/APR-246 Induces Apoptosis and Tumor Growth Delay in Small Cell Lung Cancer Expressing Mutant p53
- (2011) R. Zandi et al. CLINICAL CANCER RESEARCH
- MicroRNA miR-125b is a prognostic marker in human colorectal cancer
- (2011) Mori INTERNATIONAL JOURNAL OF ONCOLOGY
- Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer
- (2011) Mirela Nadler-Milbauer et al. JOURNAL OF DRUG TARGETING
- Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells
- (2011) Marc J. Rigatti et al. MOLECULAR CARCINOGENESIS
- Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells
- (2011) K Taketani et al. ONCOGENE
- p53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
- (2011) N. H. Kim et al. Science Signaling
- Conserved Regulation of p53 Network Dosage by MicroRNA–125b Occurs through Evolving miRNA–Target Gene Pairs
- (2011) Minh T. N. Le et al. PLoS Genetics
- Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1
- (2010) Ramesh M. Ray et al. APOPTOSIS
- The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer
- (2010) Marianne Farnebo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Current strategies to target p53 in cancer
- (2010) Fang Chen et al. BIOCHEMICAL PHARMACOLOGY
- Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition
- (2010) Christina Hackl et al. BMC CANCER
- Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells
- (2010) Sonia Rana et al. FASEB JOURNAL
- Small ubiquitin-related modifier-1: Wrestling with protein regulation
- (2010) Jessica Barry et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Translating p53 into the clinic
- (2010) Chit Fang Cheok et al. Nature Reviews Clinical Oncology
- Negative regulation of the tumor suppressor p53 gene by microRNAs
- (2010) M Kumar et al. ONCOGENE
- p53-based Cancer Therapy
- (2010) D. P. Lane et al. Cold Spring Harbor Perspectives in Biology
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells
- (2009) Takeshi Hori et al. CANCER LETTERS
- Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer
- (2008) Sharmila Patel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer
- (2008) Sanjeev Shangary et al. MOLECULAR CANCER THERAPEUTICS
- PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2
- (2008) J Shen et al. ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started